BEIJING: China will lower import tariffs on more products in high domestic demand for next year, including medical equipment, raw materials for baby powders, high-tech equipment and some commodities, the finance ministry said on Wednesday.
For 2021, China will implement temporary import tariffs, which are lower than the most-favoured-nation tariffs, on 883 products, up from 859 products taxed at temporary rates in 2020.
The tariff changes are made to satisfy domestic demand and boost the technology development of Chinese industries so that a “great circulation” of the domestic economy would be formed, said the ministry.
Facing hostilities from the United States, Beijing has unveiled a “dual circulation” strategy for the next phase of its economic development, in which it would rely mainly on “domestic circulation” – the internal cycle of production, distribution, and consumption, supported by innovation and upgrades in the economy.
To improve people’s livelihood, China will exempt import tariffs on some anti-cancer drugs and raw materials of rare disease drugs, while import duties on artificial heart valves, hearing aids, as well as some raw materials for baby powders, are to be lowered.
Beijing will also lower import duties on parts, raw materials, and industrial equipment used in its new infrastructure and high-technology push, in order to meet domestic demand. Emission-filtering devices for diesel engine vehicles would also see their import rates cut as a result of the government’s environmental drive.
Tariffs for some non-alloyed nickel and the minor metal niobium will be slightly cut in 2021 to encourage more imports, the ministry said, while sliding tariffs on cotton cargoes brought in under additional quotas will be reduced marginally, a move traders said would lower costs of importing the fiber.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor
Read all the Latest News, Breaking News and Coronavirus News here
Comments
0 comment